Literature DB >> 30997589

Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies.

F B Mollerach1,2, M Scolnik3,4, L J Catoggio3,4, J Rosa3,4, E R Soriano3,4.   

Abstract

INTRODUCTION/
OBJECTIVES: Complete congenital atrioventricular block (AVB) may be due to cardiac malformations or the presence of maternal antibodies (autoimmune AVB). Our objective was to estimate the prevalence of autoimmune AVB among all AVB in newborns treated at our hospital. Secondly, we estimated the prevalence of AVB among mothers with anti-Ro/La antibodies and examined the relationship of those fetal AVB with mother's use of hydroxychloroquine during pregnancy.
METHODS: Retrospective cohort in which we reviewed electronic medical records from years 2000 to 2014 of (a) all mothers with children born with third degree AVB and (b) all pregnant women with anti-Ro/La-positive antibodies.
RESULTS: Twenty-three AVBs were diagnosed. Ten (43.5%, 95% CI 23.2-65.5) were associated with maternal rheumatologic disease. The remaining 13 were associated with cardiac malformations. Sixty-two pregnancies in 47 mothers with Ro/La antibodies were identified; eight (12.9%, 95% CI 5.7-23.8) suffered AVB. Fourteen mothers consumed hydroxychloroquine during full pregnancy (one newborn (7.1%) suffered AVB) and 48 did not (7 newborns with AVB (14.6%); p = 0.5).
CONCLUSIONS: All congenital AVB diagnosed at our hospital without cardiac malformations were associated with a maternal rheumatologic disease/antibodies. Therefore, if a AVB is diagnosed in a newborn without structural heart disease, the mother should be studied for an autoimmune disease. We found a high prevalence of AVB among mothers with anti-Ro/La antibodies. Although not statistically significant, AVBs in mothers with Ro/La antibodies were numerically more frequent in those not using hydroxychloroquine.Key Points• Although structural heart malformations were the predominant cause of third-degree AVB, autoimmune AVB was still a significant cause.• The distinction between structural or non-structural cause of AVB constitutes an essential issue since it determines the prognostic of these fetuses in terms of complications.• Although not statistically significant, AVBs in mothers with Ro/La antibodies were more frequent in those not using hydroxychloroquine.• If an AVB is diagnosed in a newborn without structural heart disease, the mother should be studied for an autoimmune disease.

Entities:  

Keywords:  Anti-Ro/La antibodies; Atrioventricular block; Hydroxychloroquine

Mesh:

Substances:

Year:  2019        PMID: 30997589     DOI: 10.1007/s10067-019-04556-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block?

Authors:  A Ruffatti; O Milanesi; L Chiandetti; A Cerutti; M T Gervasi; G De Silvestro; V Pengo; L Punzi
Journal:  Lupus       Date:  2011-12-20       Impact factor: 2.911

2.  Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Authors:  Peter M Izmirly; Amit Saxena; Mimi Y Kim; Dan Wang; Sara K Sahl; Carolina Llanos; Deborah Friedman; Jill P Buyon
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

3.  Fetal Doppler mechanical PR interval: correlation with fetal heart rate, gestational age and fetal sex.

Authors:  A Wojakowski; G Izbizky; M E Carcano; H Aiello; P Marantz; L Otaño
Journal:  Ultrasound Obstet Gynecol       Date:  2009-11       Impact factor: 7.299

Review 4.  Neonatal lupus: bedside to bench and back.

Authors:  J P Buyon
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

5.  Pregnancy and Protection: The Ethics of Limiting a Pregnant Woman's Participation in Clinical Trials.

Authors:  Lori Allesee; Colleen M Gallagher
Journal:  J Clin Res Bioeth       Date:  2011-03-31

6.  Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.

Authors:  Deborah M Friedman; Carolina Llanos; Peter M Izmirly; Brigit Brock; John Byron; Joshua Copel; Karen Cummiskey; Mary Anne Dooley; Jill Foley; Cornelia Graves; Colleen Hendershott; Richard Kates; Elena V Komissarova; Michelle Miller; Emmanuelle Paré; Colin K L Phoon; Tracy Prosen; Dale Reisner; Eric Ruderman; Philip Samuels; Jerry K Yu; Mimi Y Kim; Jill P Buyon
Journal:  Arthritis Rheum       Date:  2010-04

7.  Hydroxychloroquine in lupus pregnancy.

Authors:  Megan E B Clowse; Laurence Magder; Frank Witter; Michelle Petri
Journal:  Arthritis Rheum       Date:  2006-11

Review 8.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 9.  Prevention and treatment in utero of autoimmune-associated congenital heart block.

Authors:  Amit Saxena; Peter M Izmirly; Barbara Mendez; Jill P Buyon; Deborah M Friedman
Journal:  Cardiol Rev       Date:  2014 Nov-Dec       Impact factor: 2.644

Review 10.  Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside.

Authors:  Jill P Buyon; Robert M Clancy; Deborah M Friedman
Journal:  Nat Clin Pract Rheumatol       Date:  2009-03
View more
  3 in total

1.  Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies.

Authors:  F B Mollerach; M Scolnik; L J Catoggio; J Rosa; E R Soriano
Journal:  Clin Rheumatol       Date:  2019-04-17       Impact factor: 2.980

2.  Reversal of Fetal Heart Block in Antibody-Positive Mother After Hydroxychloroquine and Dexamethasone.

Authors:  Mehar Hoda; William Scott; Kavita Sharma; Elaine Duryea; Catherine Ikemba
Journal:  Pediatr Cardiol       Date:  2022-06-14       Impact factor: 1.655

3.  Whole-Exome Sequencing Identifies a Novel TRPM4 Mutation in a Chinese Family with Atrioventricular Block.

Authors:  Yi Dong; Ran Du; Liang-Liang Fan; Jie-Yuan Jin; Hao Huang; Ya-Qin Chen; Dan-Dong Bi; Rong Xiang
Journal:  Biomed Res Int       Date:  2021-04-17       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.